M.E. Thomas: I guess I kind of mean I, I read articles and I read selections of books, I don't necessarily, I'm not the type of reader when I'm doing research to sit down and just read a book cover to cover. So it's difficult for me to answer that question. It's not really, how I think of reading.
Rob Kall: Okay. Okay. How, did you, I'm curious did you do research on me, and what I've been writing about this before we spoke?
M.E. Thomas: Yeah, I looked up some, some of your recent articles and a transcript from somebody from I believe earlier this, last month. Somebody who teaches at the University of Iowa?
Rob Kall: Yes. Yes, that, I, I wanted to get that transcript up before this interview. Cause I had a feeling you'd be doing the research on me. Cause that's your MO, kind of, to to figure out. And as an attorney it makes sense that you would do that, that's kind of due diligence isn't it?
M.E. Thomas: Right.
Rob Kall: Yeah, so what's, what's your impression of what I've written so far?
M.E. Thomas: The transcript was interesting, I think that, there is a lot of disagreement, and I won't even say confusion. There's a lot of disagreement about what exactly is a sociopath, and what are the primary characteristics. And I think it's because there hasn't been a lot of research. And I thought that was an interesting point in the transcript saying, you know people frequently say that sociopaths are untreatable. But there's only been one legitimate study that has even addressed that fact. And certainly it seems that we haven't exhausted the entire universe of options of possible treatments.
So to say something like that, a sociopath is untreatable. You know, to me when you hear such negative things said by very smart people, scientists who normally would be very reluctant to say some, such a blanket statement, and that's pretty, pretty unsupported. Almost wholly unsupported statement like that, then you think there must be some sort of emotional bias going on. That's at least been my experience.
Next Page 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).